LY2608204

LY2608204 · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LY2608204, covering 2018-10-03 to 2018-10-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Compare Two Forms of LY2608204 in Healthy People [Phase 1]